Suppr超能文献

前哨淋巴结辅助颈部清扫术在晚期口腔鳞状细胞癌中的应用-一种新的分期和治疗方案。

Sentinel node-assisted neck dissection in advanced oral squamous cell carcinoma-A new protocol for staging and treatment.

机构信息

Department of Clinical Sciences Intervention and Technology, Division of ENT Diseases, Karolinska Institute, Stockholm, Sweden.

Medical Unit Head Neck Lung and Skin cancer, Department of Head and Neck Surgery, Karolinska University Hospital, Stockholm, Sweden.

出版信息

Cancer Med. 2023 Jun;12(11):12524-12534. doi: 10.1002/cam4.5966. Epub 2023 Apr 21.

Abstract

BACKGROUND

Sentinel lymph node biopsy (SLNB) is used to improve the staging of and guide treatment in patients with early-stage T1-T2 N0 oral squamous cell carcinoma (OSCC). The role of sentinel nodes (SNs) and the use of SN-technique in advanced OSCC (T3-T4 and/or N+) remain to be evaluated. This study investigates the nodal drainage and the rate of positive SNs (SNs+) in all stages of OSCC.

MATERIALS AND METHODS

In total, 85 patients with T1-T4 OSCC diagnosed 2019-2021 were included. We used a prolonged interval between peritumoral injection of radionuclide and SPECT-CT to include all SNs.

RESULTS

Patients with advanced OSCC presented a higher proportion of contralateral lymphatic drainage and a higher rate of SN+ compared to patients with early-stage disease. T3-T4 and N+ tumors presented a tendency for a higher rate of contralateral lymphatic drainage compared to T1-T2 and N0 tumors (p = 0.1). The prevalence of positive nodes (SNs+) was higher among patients with advanced disease, T3-T4 versus T1-T2 (p = 0.0398).

CONCLUSION

SN-assisted ND enables identification and removal of all SNs + and has the potential for more accurate staging and could possibly give prognostic advantages regarding regional recurrence for all OSCC patients, especially among those with advanced disease. The precise localization of the SNs + also suggests that a more individualized ND approach might be possible in the future even for patients with advanced OSCC.

摘要

背景

前哨淋巴结活检 (SLNB) 用于改善 T1-T2N0 期口腔鳞状细胞癌 (OSCC) 患者的分期并指导治疗。在晚期 OSCC (T3-T4 和/或 N+) 中,前哨淋巴结 (SN) 的作用和 SN 技术的应用仍有待评估。本研究调查了所有 OSCC 分期的淋巴结引流和阳性 SN (SN+) 率。

材料和方法

共纳入 2019 年至 2021 年诊断为 T1-T4 OSCC 的 85 例患者。我们使用放射性核素肿瘤周围注射和 SPECT-CT 之间的延长间隔时间来包括所有 SN。

结果

与早期疾病患者相比,晚期 OSCC 患者表现出更高比例的对侧淋巴引流和更高的 SN+率。与 T1-T2 和 N0 肿瘤相比,T3-T4 和 N+肿瘤的对侧淋巴引流率有更高的趋势(p=0.1)。与早期疾病患者相比,晚期疾病患者中阳性淋巴结 (SNs+) 的患病率更高,T3-T4 与 T1-T2 相比(p=0.0398)。

结论

SN 辅助 ND 能够识别和切除所有 SNs+,具有更准确分期的潜力,并可能为所有 OSCC 患者,特别是晚期疾病患者,提供区域复发的预后优势。SNs+的精确定位还表明,即使对于晚期 OSCC 患者,未来也可能采用更个体化的 ND 方法。

相似文献

1
Sentinel node-assisted neck dissection in advanced oral squamous cell carcinoma-A new protocol for staging and treatment.
Cancer Med. 2023 Jun;12(11):12524-12534. doi: 10.1002/cam4.5966. Epub 2023 Apr 21.
2
Sentinel node biopsy for oral cancer: A prospective multicenter Phase II trial.
Auris Nasus Larynx. 2017 Jun;44(3):319-326. doi: 10.1016/j.anl.2016.07.008. Epub 2016 Aug 3.
5
Topographical distribution of sentinel nodes and metastases from T1-T2 oral squamous cell carcinomas.
Eur J Cancer. 2019 Jan;107:86-92. doi: 10.1016/j.ejca.2018.10.021. Epub 2018 Dec 12.
6
Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer.
Eur J Cancer. 2015 Dec;51(18):2777-84. doi: 10.1016/j.ejca.2015.08.023. Epub 2015 Nov 18.
9
A Novel Sentinel Lymph Node Approach in Oral Squamous Cell Carcinoma.
Curr Pharm Des. 2020;26(31):3834-3839. doi: 10.2174/1381612826666200213100750.
10
Sentinel lymph node biopsy in recurrent or secondary oral squamous cell carcinoma after previous neck dissection.
Oral Oncol. 2023 Oct;145:106494. doi: 10.1016/j.oraloncology.2023.106494. Epub 2023 Jul 28.

引用本文的文献

1
Six-month mortality has decreased for patients with curative treatment intent for head and neck cancer in Sweden.
PLoS One. 2024 Apr 16;19(4):e0296534. doi: 10.1371/journal.pone.0296534. eCollection 2024.
2
A novel near-infrared EGFR targeting probe for metastatic lymph node imaging in preclinical mouse models.
J Nanobiotechnology. 2023 Sep 22;21(1):342. doi: 10.1186/s12951-023-02101-z.

本文引用的文献

1
High Failure Rates in Young Nonsmoker Nondrinkers With Squamous Cell Carcinoma of the Oral Tongue.
Laryngoscope. 2023 May;133(5):1110-1121. doi: 10.1002/lary.30253. Epub 2022 Jun 18.
5
Diverging incidence trends of oral tongue cancer compared to other head and neck cancers in young adults in France.
Int J Cancer. 2022 Apr 15;150(8):1301-1309. doi: 10.1002/ijc.33896. Epub 2021 Dec 24.
6
Novel double injection technique for sentinel lymph node biopsy in oral cancer.
Br J Oral Maxillofac Surg. 2021 Dec;59(10):1296-1301. doi: 10.1016/j.bjoms.2021.07.008. Epub 2021 Jul 17.
7
Sentinel Lymph Node Biopsy Versus Elective Node Dissection in Stage cT1-2N0 Oral Cavity Cancer.
Laryngoscope. 2022 May;132(5):989-998. doi: 10.1002/lary.29895. Epub 2021 Oct 12.
8
Clinical outcome and prognostic factors in recurrent oral squamous cell carcinoma after primary surgical treatment: a retrospective study.
Clin Oral Investig. 2022 Feb;26(2):2055-2064. doi: 10.1007/s00784-021-04186-y. Epub 2021 Sep 28.
9
Practical aspects of sentinel node biopsy in oral cavity cancer: all nodes that emit a signal are important.
Acta Otolaryngol. 2021 Aug;141(8):820-824. doi: 10.1080/00016489.2021.1945681. Epub 2021 Jul 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验